logo
Plus   Neg
Share
Email

Bristol-Myers Squibb To Become Limited Partner Of BioMotiv - Quick Facts

BioMotiv and Bristol-Myers Squibb (BMY) have entered a strategic partnership to develop new therapies. Bristol-Myers Squibb will become a limited partner of BioMotiv with the option to invest additional funding in selected projects. BioMotiv and Bristol-Myers will form and fund new companies to develop therapeutics in disease areas where unmet medical needs remain.

Bruce Car, Interim Head, Discovery Research, Bristol-Myers, said: "Partnering with an innovative accelerator like BioMotiv strengthens our ability to translate cutting edge, early-stage academic discoveries into new therapies for patients with serious diseases."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Drugstore chain Walgreens and courier services provider Postmates said they have expanded on-demand delivery to more than 7,000 Walgreens stores nationwide. The companies expect the service will help capitalize on the rising need for home delivery amid the coronavirus pandemic. The expansion will enable consumers in cities across the country to get home delivery of health and wellness items. A growing number of retailers in the U.S. are furloughing their employees as the coronavirus pandemic has resulted in the temporary closure of retail stores nationwide. The store closures came as more people in the U.S. are forced to remain at home to help curtail the spread of COVID-19 by promoting social distancing. Ride-hailing giant Uber Technologies said it is offering 10 million free rides and food deliveries to healthcare workers, seniors, and people in need, amid the surging coronavirus or covid-19 crisis. Across the world, the company aims to work with more cities, food banks, hospitals and others to move what matters, such as getting first responders to work, and food to those who need it.
Follow RTT
>